chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had three shots; Had three shots and just got it/suspected vaccination failure; Had three shots and just got it; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis and Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 3rd dose of Shingles vaccine, the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On 23-MAR-2023, an unknown time after receiving Shingles vaccine, Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had three shots and just got it/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Had three shots and just got it). On an unknown date, the patient experienced extra dose administered (Verbatim: I had three shots) (serious criteria GSK medically significant). The outcome of the vaccination failure and extra dose administered were unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine, Shingles vaccine and Shingles vaccine.  It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine, Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 23-MAR-2023 This case was reported by a patient via interactive digital media. The reporter stated that he/she got more than one shingles vaccine. The patient received three doses of shingles vaccine and diagnosed with shingles at the time of reporting. This case was considered as suspected vaccination failure since the details time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The patient received three doses of shingles vaccine, which led to extra dose administered. The follow up would not possible as no contact details were available.
Patient experienced redness and swelling around the site of injection (about 6 inches in diameter). She also reported extreme pain, greater than that of any other vaccine she has had in the past.
This spontaneous report was received from  a Nurse via company representative refers to an adult (also reported as in her 20's) female patient of unknown age. The patients' medical history, concurrent conditions and concomitant medications were unknown. On an unknown date, the patient was vaccinated with GARDASIL (strength, dose, frequency, lot number, anatomical location and expiration date unknown) for prophylaxis. It was reported that right after receiving the vaccine the patient got sick and was hospitalized. The patient was diagnosed with lupus (systemic lupus erythematous). The outcome of systemic lupus erythematosus was unknown. The causality assessement between GARDASIL and lupus was not reported. Upon internal review the event lupus was determined to be medically significant. There was no product quality complaint associated with this report.
Breakthrough case admission after 2 vaccines ; Moderna 5/10/21 Lot# 003C21A;  Moderna 6/7/21 Lot# 049C21A
lung issues from COVID came back; cough with phlegm; can't speak properly because she loses her breath; muscle aches; very fatigued; chills/ teeth were chattering; fever; headache/ tremondous headache; muscle cramping; couldn't sleep; stomach started to sear; This spontaneous case was reported by a consumer and describes the occurrence of LUNG DISORDER (lung issues from COVID came back), PRODUCTIVE COUGH (cough with phlegm), ABDOMINAL DISCOMFORT (stomach started to sear), DYSPNOEA (can't speak properly because she loses her breath) and MUSCLE SPASMS (muscle cramping) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach started to sear), MUSCLE SPASMS (muscle cramping), INSOMNIA (couldn't sleep), CHILLS (chills/ teeth were chattering), PYREXIA (fever) and HEADACHE (headache/ tremondous headache). On 16-Apr-2021, the patient experienced LUNG DISORDER (lung issues from COVID came back), PRODUCTIVE COUGH (cough with phlegm), DYSPNOEA (can't speak properly because she loses her breath), MYALGIA (muscle aches) and FATIGUE (very fatigued). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 18-Apr-2021, ABDOMINAL DISCOMFORT (stomach started to sear), MUSCLE SPASMS (muscle cramping), INSOMNIA (couldn't sleep), MYALGIA (muscle aches), CHILLS (chills/ teeth were chattering), PYREXIA (fever) and HEADACHE (headache/ tremondous headache) had resolved. At the time of the report, LUNG DISORDER (lung issues from COVID came back), PRODUCTIVE COUGH (cough with phlegm), DYSPNOEA (can't speak properly because she loses her breath) and FATIGUE (very fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported.
vial was initially stored in the refrigerator on 31-May-2022 and vaccine was administrated on 01-Jul-2022.; doses of Moderna vaccine administered beyond 30 day use by date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses of Moderna vaccine administered beyond 30 day use by date) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 31-May-2022 and vaccine was administrated on 01-Jul-2022.) in a 66-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 054A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 01-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 01-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses of Moderna vaccine administered beyond 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 31-May-2022 and vaccine was administrated on 01-Jul-2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses of Moderna vaccine administered beyond 30 day use by date) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 31-May-2022 and vaccine was administrated on 01-Jul-2022.) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. It was reported that 8 doses were administered from the expired vial. vial was initially stored in the refrigerator  on 31-May-2022 4PM ,went from freezer to refrigerator and vaccine was administrated on 01-Jul-2022 between 9am and 12noon. No temperature excursions. Treatment details were not reported by the reporter.
Notice Td vaccine reaction on 7/28/08.  L deltoid apply ice packed.  Red induration swelling 4 inches x 4 inches.
Within months started to feel tired and gain weight exponentially. Went to gynecologist but they did genetic lab work for thyroid and numbers were 'normal' but I was still having symptoms, after years I went to a specialist and after 2 rounds of lab work Hashimoto's was diagnosed.
pt had loc   fell to floor  0 rash wheezing itching hives redness swelling
Patient received the Flu vaccine on 9/27/14. On 9/30/14 he developed a fever (101.3) and N w/o V, diarrhea, diaphoresis and abd. cramping. By Thursday, temp increased to 102.8. On 10/3/14 he was admitted to the Hospital until 10/6/14. Thought to be related to Flu vaccine due to egg connection.
Typical reaction to tetanus shot the day of and 1st 24 hrs ( tenderness in area).  Unable to move arm actively into extension or able to abduct, internal rotation more painful than external rotation. Only able to move arm into extension and abduction passively. Have been to doctor 3 x's since reaction. to include family practitioner, NP at orthoclinic. Pain is present 24/7 since shot was given. Prednisone does decrease pain but not well tolerated. This adverse reaction is 100 % affecting my job as a personal trainer and coach.
I95.9 HYPOTENSION 9/20/2021 SEPSIS UNSPECIFIED ORGANISM
At unspecified times, the pt received his first 2 injections with Lymerix, with no untoward effects. Sometime after receiving the 3rd dose of Lymerix, he experienced a rash around the injection site. The information received on 6/14/2000, reported the symptoms were ongoing.
patient reported that the following evening the site began to itch.  the next day the site became red and swollen which gradually increased. The symptoms  itching, swelling, erythema with mild cellulitis.  She was treated with a Medrol Dose pack to be started 5/19/19 and if site not improved to begin Keflex 500mg bid for 7 days.  follow up call on 5/20 the patient reported she forgot to start the Medrol dose pack but the site had not gotten worse or increased in size beyond the marked area from the clinic visit the prior day.
02/04/13 given ZOSTIVAX vaccine around 5pm, site of injection under side of arm 3" above elbow (pharmacist dropped the vaccine vial and failed to wipe the vials and my arm off properly) 30 hrs. later admitted in to ER with severe pain on upper left side (chin to armpit down to the tip of my fingers), treated with antibiotics and pain meds, returned to ER 48 hours later with worsening infection (fever, chills, and increased pain. Red swollen area around injection increased to several inches in diameter.
Left (injected) arm was swollen; Left (injected) arm / red; Left (injected) arm / warm to the touch; This case was reported by a consumer via call center representative and described the occurrence of swelling arm in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 2 years after receiving Shingrix, the patient experienced swelling arm, erythema of extremities and skin warm. On an unknown date, the outcome of the swelling arm, erythema of extremities and skin warm were recovered/resolved.   It was unknown if the reporter considered the swelling arm, erythema of extremities and skin warm to be related to Shingrix.  Additional details provided as follows: The patient reported case for herself. The age at vaccination was not reported. The reporter did not provided lot no. and expiry date of vaccine. The patient got her first Shingrix shot in August or September 2019. The patient reported that her left (injected) arm was swollen, red and warm to the touch for a few days post vaccination. All the events were resolved. This case has been linked with case US2021054993, reported by same reporter for same patient. The patient did not consent to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021054993:Same reporter, same patient, 2nd dose
It started out with fatigue, dizziness. I then took COVID-19 test and it was positive. I tested positive at an urgent care. I was prescribed a medication. The second day I had diarrhea, slight sore throat and headache for about 4 days. On the 4th day I got congestion in my lungs and coughed up mucus. I also experienced UTI.
Fever, chills, aches, nausea, vomiting, diarrhea, fatigue, lightheaded and headache. Took Tylenol ate broth and drank water.
Client at clinic accompanied by parent (mother) for 11 YO Immunizations. Client properly identified by name and DOB. Client properly screened for allergies (food/medication) and medical conditions. As per mother statement client has no allergies and no medical conditions. Client and parent explained vaccines about to received. Parent provided VIS. Questions/concerns parent had were answered by nurse. Nurse started administering Flu and MCV4 vaccines at 2:00PM on left arm without any problems/reactions.  Nurse continued to administer Tdap and HPV9 vaccines to right arm. Around 2:01PM when nurse just finished giving client HPV9 vaccine client fainted and started shaking legs and arms for less than 5 seconds. Client quickly regained consciousness but looked "spaced-out" and pale. 2:05PM  Vitals signs were checked and blood pressure was low and pulse was normal. Ambulance was called. In the mean time, vitals signs were monitored, blood pressure stabilized by 2:12PM client remain conscious but continued to looked "spaced-out". 2:30PM ambulance and paramedics arrived. Vital signs checked and normal. RBS checked and normal. 2:40PM client threw up. 2:46PM client left clinic in ambulance going to Hospital and accompanied by mother.
Dizziness, ringing of ears, pallor, feel of faint/poss faint.
Extreme muscle pain and soreness in the buttocks and legs from Sep 15?18. I was unable to sleep on Sep16 because of the pain. On Sep 18 leg soreness subsided, but feet felt numb and it was nearly impossible to stand in place and bending over to pick something up off the floor is painful. I could walk, but with difficulty. Sep 20 to now the numbness has gotten much better, but it's totally gone.
Patient developed life-challenging pericarditis approximately 7 days following vaccination #2 (given on May 1, 2021) causing fever, DOE and prompting emergent hospitalization followed by surgery for a pericardial window.  The patient continued to have fever after the pericardial window and has been treated for possible flare of her  arteritis with increased prednisone and increased CellCept.  Prior to vaccination she had been in remission for at least 24 months on prednisone 1 mg per day and CellCept 500 mg twice per day.
Approximately 3 weeks post vax the pt was seen by a pediatrician who indicated that the infant had developed an urticarial type rash and increased temperature. A diagnosis of Henoch-Schonlein purpura was made. At the date of the office visit the infant experienced a 30 minute period of uncontrollable crying. Blood culture and CT performed on 09/07/2000 were negative. The infant recovered. A copy of this report has been forwarded to Aventis Pasteur, maker of the concomitantly administered vaccines.
Severe headache, sensitivity to light, nausea, fatigue, no appetite, pain/soreness/warm to touch at injection site. Adverse events lasted 46 hours, 240 mg naproxen taken 4x with no improvement of side effects. Symptoms improved with time and sleep.
This case was reported by a consumer (father of subject) and described the occurrence of droopy eyelid in a 2-month-old female subject who was vaccinated with INFANRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. On 15 July 2013 the subject received 1st dose of INFANRIX (unknown details). On 27 July 2013, 12 days after vaccination with INFANRIX, the subject experienced droopy eyelid and jerking of head (described as "jerky head movements". The subject had not had any other vaccinations at the time of reporting. The father reported that medical attention was required at the doctor's office. At the time of reporting the events were unresolved.
He was very sick from the booster shot; The patient states he was freezing, chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (He was very sick from the booster shot) and CHILLS (The patient states he was freezing, chills) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 061E21A, 045A21A and 025A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (He was very sick from the booster shot) and CHILLS (The patient states he was freezing, chills). At the time of the report, ILLNESS (He was very sick from the booster shot) and CHILLS (The patient states he was freezing, chills) outcome was unknown.            Concomitant medications were not reported. Treatment information was not provided.   This case was linked to MOD-2021-066438 (Patient Link).
2/19/22 Diagnosed with Unspecified Heart Failure with Ejection fraction 15-20%, No family history of Cardiac disease, COVID TESTING NEGATIVE, Healthy Female up until November/Decemb2021. November/December 2021 - SOB with cough- treated as viral illness with pneumonia used inhaler, antibiotic and steroids' February 2022 SOB with cough- treated as viral illness then worsening and to emergency room 2/19/22
Pt. states that after receiving the 2nd dose of Phizer 10/14/2021, started experiencing symptoms 12mins after of weakness, shortness of breath, dizziness, uncontrollable shaking, HBP, headache, fever, and fatigue. Transported to Emergency Department Hospitalized until 10/21/2021. Still experiencing symptoms.
This case was reported by a other health professional via call center representative and described the occurrence of influenza-like symptoms in a 51-year-old male patient who received SHINGRIX (batch number 5G7A7, expiry date 8th May 2021) for prophylaxis. On 24th January 2019, the patient received the 1st dose of SHINGRIX. On 24th January 2019, 8 hrs after receiving SHINGRIX, the patient experienced influenza-like symptoms, fever, headache, general body pain, fatigue and injection site pain. On an unknown date, the outcome of the influenza-like symptoms, fever, headache, general body pain, fatigue and injection site pain were not recovered/not resolved. It was unknown if the reporter considered the influenza-like symptoms, fever, headache, general body pain, fatigue and injection site pain to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX in the right deltoid. The patient experienced flu-like symptoms, soreness at injection site, fever, headache, body ache, and fatigue following vaccination with SHINGRIX. The reporter gave consent to follow up.
On Friday, Feb 19th, I started feeling nauseated, and dizzy, on Saturday Feb 20th, I started having chest pain, I do have angina but the pains have occurred more often since getting the vaccine.
Approx. 15-20 minutes after receiving 2 vaccine pt. complained of severe back + leg cramps. 911 was called. Paramedics monitored pt for 10 minutes then released her to go. Vitals were normal
Stiff neck on the right side, same side as shot was given. An ongoing headache, even to the current day.
Began with sore throat, tight chest and sinus pressure.  Within two hours, it progressed to a fever, headache, extreme overall body aches and weakness, dizziness and lack of appetite.
patient stated her arm started burning , swelling and turned red and swollen from shoulder to elbow over a period of 2 days. she took benadryl with little relief since she thought it was an allergic reaction. presented monday with large area from shoulder to elbow still swollen and tender to touch.
Swollen upper arm and tender for 2 days after the injection.  The ringworm rash seemed to spread like wildfire on the third day and within a couple of days, both my legs were covered with the blotches.  I had continued using the tolnaftate but on Saturday the 13th of March I went to get medical advise at the local ER and was told to take Allegra and Clotrimazole-Betamethazone cream.  The rash got worse and I called Dr. and he told me to contniue to take the Allegra but stop the cream and start with Lotrimin because the Betamethazone in the cream counteracts the positive effects of the Clotrimazole.
pt recv vax 9MAR98 & the next day pt exp a local rxn consisting of redness & warmth;
Patient complained of pinched nerve pain after vaccination that she couldn?t sleep and perform well at work.
About 4-5 hours afterwards, arm became hard to move.  By the following morning, it was extremely painful with swelling. Almost no range of motion.  Pain was (and still is) enough to wake me at night.  Tried Advil and Tylenol with no effect.  After 5 days, made an appointment with my primary care physician.  The PA said I had SIRVA and prescribed physical therapy.  Physical therapist says that the injury is either to the rotator cuff or bursa and that will continue for several weeks.  Severe pain is has led to referral to an orthopedist.   I am 9 days out and especially in the morning, the pain is severe and continuing.
Left shoulder/arm pain and decreased strength for several months following injection. No prior pain  or injury.   Primary care doctor referred me to an orthopedist for an evaluation.  After normal looking xrays, he ordered physical therapy.  I am currently undergoing physical therapy for my left shoulder and will be discharged soon.
Had flu shot on 12/4/07.  12/6/07 awoke with facial swelling, particularly about the eyes.  Has no symptoms of URI or sensitivity.  No fever.  Patient felt this was a reaction to flu shot.  Patient 22 weeks pregnant.
Fatigue, chills, fever, exhaustion. The following Sunday, 9 days after his second dose he went to bed and never woke up.
Incorrect mRNA COVID-19 vaccine was inadvertently administered for a first booster dose. A patient had an incomplete vaccine record in and received a monovalent COVID-19 dose instead of the bivalent dose they should have received. Medical Director was contacted, and the patient was briefed by clinic staff about having received the incorrect dose. No adverse physiological effects occurred, and patient was instructed to seek a bivalent booster dose in 2 months.
Initial unsolicited report received from a nurse on 28-Nov-2017. This case involves a male patient (age not reported) who was vaccinated with a dose of FLUZONE QIV (lot number: U589DA, expiry date, route and site of administration were not reported) on an unspecified date. The patient's medical history and concomitant medications were not reported. On an unspecified date, post-vaccination, the patient had experienced large red rash. Relevant lab investigations and corrective treatment were not reported. Outcome of the event was not reported. List of documents held by sender: none.
This spontaneous report was received from a registered nurse concerning to a patient of unknown age and gender. Concurrent conditions or pertinent medical history were not reported. On 04-APR-2016, the patient was inadvertently vaccinated with an expired dose of ROTATEQ (lot # K007246, expiration date: 17-MAR-2016), orally (dose and frequency were unspecified). Concomitant medications were unspecified. No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
This spontaneous report as received from a healthcare worker refers to 2 patients of unknown. On an unknown date the 2 patients were vaccinated intramuscularly with the first 0.5 ml dose of PNEUMOVAX23 (lot # 0709AE, expiry date on 04-JAN-2014) in the arm. With 24 hours after vaccination, the 2 patients experienced redness and swelling of arm at the injection site, fever and nausea. Action taken regarding PNEUMOVAX23 was not reported. The outcome of all events is unknown. The 2 patients sought unspecified medical attention. The relationship between the events and PNEUMOVAX23 was not reported. Additional information has been requested.
Severe headache the next day after vaccine, treatment included Aleve PM that evening post vaccine with second day residual headache and today completely resolved.  Headache did not interfere with ADLs